Skip to main content
. 2011 Nov;13(11):783–791. doi: 10.1111/j.1477-2574.2011.00355.x

Table 1.

Transition probability estimates from the literature with ranges used for sensitivity analyses

Transition probabilities Baseline value Range References
Radiofrequency ablation

 Post-procedure mortality 1% 1–3%

 Decompensation 5% 3–10% 30,3341

 5-year survival 35% 15–50%

 Annual HCC recurrence 50% 25–70%

Hepatic resection

 Postoperative mortality 3% 1–7%

 Decompensation 5% 3–10% 4249

 5-year survival 55% 40–70%

 Annual HCC recurrence 20% 15–35%

Primary liver transplant

 Waitlist dropout/death 20% 10–40% 24,4248

 Postoperative mortality 5% 3–8%

 5-year survival 70% 60–80%

Salvage liver transplant

 Waitlist dropout/death 10% 10–40% 24,39,4248

 Postoperative mortality 8% 3–10%

 5-year survival 70% 60–80%

Cost, US$

 Compensated cirrhosis/year 5 000 3 000–10 000

 RFA 5 000 2 500–10 000

 Hepatic resection 35 000 25 000–60 000 30,35,50,51

 Post-RFA/resection care/year 3 500 1 000–5 000

 Liver transplant 150 000 100 000–200 000

 Post-OLT care/year 12 000 10 000–25 000

Utilities, QALY

 Compensated cirrhosis 0.7 0.5–0.8

 Post-RFA 0.7 0.5–0.8

 Post-RFA recurrence 0.5 0.4–0.8 30,40,5053

 Post-resection 0.7 0.5–0.8

 Post-resection recurrence 0.5 0.4–0.8

 Post-liver transplant 0.8 0.6–0.9

HCC, hepatocellular carcinoma; RFA, radiofrequency ablation; OLT, orthotopic liver transplantation; QALY, quality-adjusted life year